Reglagene’s First Peer-reviewed Article Published in Biomedicines, as part of the Special Issue Glioblastoma

Today marks a momentous occasion for Reglagene as we proudly announce the publication of our first peer-reviewed article titled "Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma" in Biomedicines, as part of the Special Issue Glioblastoma.
 
A huge congratulations to the Reglagene team behind this groundbreaking work: Lilian Patrón, Helen Yeoman, Sydney Wilson, Vijay Gokhale, and Teri Suzuki. We also extend our congratulations to our collaborators at the Translational Genomics Research Institute, Nanyun Tang, and Michael Berens.
 
This publication marks a significant milestone in showcasing the potential of our proof-of-concept compound, RGN3067. Keep your eyes peeled for our next publication, which will spotlight our lead Asset, RGN6024. Link to the full publication: https://www.mdpi.com/2227-9059/12/2/406